Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the EBITDA margin high or low?
The EBITDA margin of 24.44% is in line with its 5-year average of 24.42%, around the middle of its 5-year range (20.84%–31.90%).
6.74% above its 12-month average of 22.90%.
Reported quarterly EBITDA margin; no daily interpolation. Q2 FY2026 (2026-06-27): 21.44%.
EBITDA MARGIN
24.44%
EBITDA MARGIN AVG TTM
22.90%
EBITDA MARGIN AVG 3Y
24.78%
EBITDA MARGIN AVG 5Y
24.42%
EBITDA MARGIN AVG 10Y
25.07%
EBITDA MARGIN AVG 15Y
23.83%
EBITDA MARGIN AVG 20Y
22.65%
CURRENT VS TTM AVG
+6.74%
CURRENT VS 3Y AVG
-1.36%
CURRENT VS 5Y AVG
+0.10%
CURRENT VS 10Y AVG
-2.51%
CURRENT VS 15Y AVG
+2.55%
CURRENT VS 20Y AVG
+7.90%
Thermo Fisher Scientific Inc.
Market Cap
$233.32B
EBITDA Margin
24.44%
TTM Avg
22.90%
3Y Avg
24.78%
5Y Avg
24.42%
Market Cap
$179.63B
EBITDA Margin
49.12%
TTM Avg
32.26%
3Y Avg
34.27%
5Y Avg
33.90%
Market Cap
$176.57B
EBITDA Margin
24.35%
TTM Avg
24.15%
3Y Avg
24.77%
5Y Avg
25.59%
Market Cap
$144.68B
EBITDA Margin
30.87%
TTM Avg
31.21%
3Y Avg
32.47%
5Y Avg
31.98%
Market Cap
$130.54B
EBITDA Margin
35.99%
TTM Avg
34.83%
3Y Avg
32.83%
5Y Avg
33.22%
| NAME | MARKET CAP | EBITDA MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Thermo Fisher Scientific Inc. (TMO) | $233.32B | 24.44% | 22.90% | 24.78% | 24.42% |
| AstraZeneca PLC (AZN)vs › | $252.35B | 33.16% | 30.52% | 27.50% | 25.68% |
| Amgen Inc. (AMGN)vs › | $202.99B | 43.12% | 40.78% | 43.34% | 44.32% |
| Novo Nordisk A/S (NVO)vs › | $189.15B | 48.42% | 49.59% | 48.46% | 47.82% |
| Gilead Sciences, Inc. (GILD)vs › | $179.63B | 49.12% | 32.26% | 34.27% | 33.90% |
| Abbott Laboratories (ABT)vs › | $176.57B | 24.35% | 24.15% | 24.77% | 25.59% |
| Pfizer Inc. (PFE)vs › | $156.85B | 32.51% | 34.72% | 32.84% | 32.73% |
| Danaher Corporation (DHR)vs › | $144.68B | 30.87% | 31.21% | 32.47% | 31.98% |
| Intuitive Surgical, Inc. (ISRG)vs › | $130.54B | 35.99% | 34.83% | 32.83% | 33.22% |
| Vertex Pharmaceuticals Incorporated (VRTX)vs › | $130.27B | 41.14% | 20.45% | 32.86% | 36.27% |
Gross Margin
40.4%
EBITDA Margin
24.4%
Operating Margin
17.7%
Net Margin
15.1%
Formula: EBITDA Margin = (EBITDA / Revenue) × 100
Why EBITDA Margin matters:
EBITDA Margin = EBITDA / Revenue
EBITDA margin measures operating profitability before interest, taxes, depreciation, and amortization as a percentage of revenue.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EBITDA MARGIN |
|---|---|
| 2026-06-27 | 21.44% |
| 2026-03-28 | 20.84% |
| 2025-12-31 | 24.80% |
| 2025-09-27 | 23.43% |
| 2025-06-28 | 23.97% |
| 2025-03-29 | 24.56% |
| 2024-12-31 | 26.42% |
| 2024-09-28 | 25.06% |
| 2024-06-29 | 24.17% |
| 2024-03-30 | 24.71% |
| 2023-12-31 | 26.00% |
| 2023-09-30 | 26.74% |
| 2023-07-01 | 24.67% |
| 2023-04-01 | 23.93% |
| 2022-12-31 | 24.74% |
| 2022-10-01 | 24.30% |
| 2022-07-02 | 25.31% |
| 2022-04-02 | 31.32% |
| 2021-12-31 | 31.41% |
| 2021-10-02 | 31.90% |
| 2021-07-03 | 31.39% |
| 2021-04-03 | 37.31% |
| 2020-12-31 | 35.43% |
| 2020-09-26 | 34.81% |
| 2020-06-27 | 29.22% |
| 2020-03-28 | 24.45% |
| 2019-12-31 | 27.02% |
| 2019-09-28 | 24.92% |
| 2019-06-29 | 25.76% |
| 2019-03-30 | 24.51% |
| 2018-12-31 | 26.82% |
| 2018-09-29 | 24.39% |
| 2018-06-30 | 25.19% |
| 2018-03-31 | 24.24% |
| 2017-12-31 | 26.18% |
| 2017-09-30 | 25.14% |
| 2017-07-01 | 25.15% |
| 2017-04-01 | 24.64% |
| 2016-12-31 | 26.67% |
| 2016-10-01 | 25.11% |
| 2016-07-02 | 23.65% |
| 2016-04-02 | 21.75% |
| 2015-12-31 | 23.96% |
| 2015-09-26 | 24.03% |
| 2015-06-27 | 23.78% |
| 2015-03-28 | 23.06% |
| 2014-12-31 | 23.77% |
| 2014-09-27 | 26.27% |
| 2014-06-28 | 18.11% |
| 2014-03-29 | 31.79% |
| 2013-12-31 | 20.31% |
| 2013-09-28 | 20.13% |
| 2013-06-29 | 19.28% |
| 2013-03-30 | 19.99% |
| 2012-12-31 | 20.10% |
| 2012-09-29 | 19.36% |
| 2012-06-30 | 19.57% |
| 2012-03-31 | 19.31% |
| 2011-12-31 | 18.82% |
| 2011-10-01 | 18.32% |
| 2011-07-02 | 16.17% |
| 2011-04-02 | 18.59% |
| 2010-12-31 | 19.13% |
| 2010-10-02 | 18.90% |
| 2010-07-03 | 19.00% |
| 2010-04-03 | 18.42% |
| 2009-12-31 | 18.72% |
| 2009-09-26 | 16.74% |
| 2009-06-27 | 16.35% |
| 2009-03-31 | 16.87% |
| 2008-12-31 | 19.53% |
| 2008-09-27 | 18.78% |
| 2008-06-28 | 19.56% |
| 2008-03-29 | 19.15% |
| 2007-12-31 | 18.38% |
| 2007-09-29 | 18.39% |
| 2007-06-30 | 18.03% |
| 2007-03-31 | 16.15% |
| 2006-12-31 | 9.07% |
| 2006-09-30 | 15.85% |
| 2006-07-01 | 15.60% |
| 2006-04-01 | 15.37% |
| 2005-12-31 | 17.06% |
| 2005-10-01 | 14.72% |
| 2005-07-02 | 12.70% |
| 2005-04-02 | 13.81% |
| 2004-12-31 | 13.83% |
| 2004-10-02 | 14.00% |
| 2004-07-03 | 13.81% |
| 2004-04-03 | 12.95% |
| 2003-12-31 | 11.96% |
| 2003-09-27 | 11.45% |
| 2003-06-28 | 12.26% |
| 2003-03-29 | 10.66% |
| 2002-12-31 | 9.29% |
| 2002-09-28 | 11.35% |
